Chemotherapy Doesn’t Increase the Risk of COVID-19 or Related Death in Patients with Breast Cancer, Study Suggests

Chemotherapy was not associated with increased risks of SARS-CoV-2 infection or COVID-19-related death in patients with breast cancer in a single-center study. The study results were presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting by Nibash Budhathoki, MBBS, of the NYU Long Island School of Medicine in Mineola, New York. Dr. Budhathoki and colleagues analyzed data on breast cancer patients treated at NYU Long Island School of Medicine to determine the incidence of SARS-CoV-2 infection and COVID-19-related mortality by treatment type.

https://www.cancertherapyadvisor.com/home/news/conference-coverage/asco-2021/asco-2021-breast-cancer-in-depth/breast-cancer-chemotherapy-covid19-risk-related-death-treatment/